OTCMKTS:NVZMY Novozymes A/S Q4 2025 Earnings Report $65.02 -2.41 (-3.57%) As of 09/25/2026 03:59 PM Eastern ProfileEarnings HistoryForecast Novozymes A/S EPS ResultsActual EPS$0.35Consensus EPS $0.79Beat/MissMissed by -$0.44One Year Ago EPSN/ANovozymes A/S Revenue ResultsActual Revenue$1.18 billionExpected Revenue$1.22 billionBeat/MissMissed by -$41.55 millionYoY Revenue GrowthN/ANovozymes A/S Announcement DetailsQuarterQ4 2025Date2/25/2026TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AUpcoming EarningsNovozymes A/S' next earnings date is estimated for Thursday, November 5, 2026, based on past reporting schedules. Conference Call ResourcesEarnings HistoryCompany Profile Novozymes A/S Earnings HeadlinesHead-To-Head Survey: CF Industries (NYSE:CF) and Novozymes A/S (OTCMKTS:NVZMY)September 26 at 4:31 AM | americanbankingnews.comNovozymes A/S (NVZMY) Q2 2026 Earnings Call TranscriptAugust 20, 2026 | seekingalpha.comMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up Amazon and Netflix under $3 per share in 2005. Now the chief investment strategist at The Oxford Club has identified three AI stocks he believes could be the most profitable investments of the next decade.September 26 at 1:00 AM | The Oxford Club (Ad)Novonesis (Novozymes) B ADR NVZMYAugust 5, 2026 | morningstar.comMNovozymes AS DRC (NVZMY)June 24, 2026 | investing.comA Look At Novozymes (CPSE:NSIS B) Valuation After Recent Share Price WeaknessMay 14, 2026 | uk.finance.yahoo.comSee More Novozymes A/S Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Novozymes A/S? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Novozymes A/S and other key companies, straight to your email. Email Address About Novozymes A/SNovozymes A/S (OTCMKTS:NVZMY) was a Danish biotechnology company that developed and commercialized enzymes, microorganisms and other biological solutions for industrial and consumer applications. Its technologies were designed to help customers improve production efficiency, reduce resource use and develop more sustainable products and processes. The company supplied biological products and related solutions to a range of industries, including food and beverages, household care, agriculture, animal health, bioenergy and industrial manufacturing. Its portfolio included enzymes used in areas such as baking, brewing, dairy production, detergents, textiles, biofuels and technical processing, as well as microbial products for agricultural and other biological applications. Novozymes was established in 2000 through the demerger of the enzyme activities of Novo Nordisk and was headquartered in Bagsværd, Denmark. It served customers internationally through research, production and commercial operations across multiple regions. In January 2024, Novozymes combined with Chr. Hansen Holding A/S to form Novonesis, a biosolutions company. As a result, Novozymes is primarily of historical interest as a separately listed company, and its former operations are now part of Novonesis.View Novozymes A/S ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 09/21 - 09/25Costco Ends Its Fiscal Year on a High Note, Eyes Big ExpansionCracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic ProblemDarden Restaurants Serves Up Fresh Catalysts for a Stock Price RallySoFi Is Bypassing the Banking Bottleneck With Stablecoin SettlementSuper Micro’s Vera Rubin Shipments Put Its AI Infrastructure Advantage to the TestHims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks Upcoming Earnings Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
